Dr. Jens R. Wendland is a Venture Partner at Forbion and is also the chief medical officer at Kynexis, a Forbion portfolio company.
He was trained as a physician in Germany. Following an internship in adult psychiatry, he worked as a post-doctoral fellow with Drs. Dennis Murphy and Francis McMahon at the National Institute of Mental Health in Bethesda, MD, on the genetics of psychiatric disorders. Before Kynexis, Jens held various pharmaceutical industry positions of increasing responsibility at Roche, Pfizer, Nestlé Health Science, and Takeda.
His focus is on neuroscience, rare diseases, drug development, and translational medicine, with particular emphasis on using human genetics to identify compelling drug targets and responder sub-populations.
